In the present study, tryptophan alleviated CRS-induced intestinal leakage and decreased apoptosis, as evidenced by its inhibition of IFABP, FITC-dextran, and TUNEL-positive cell levels. This evidence concerns the gene FABP2 and congenital rubella syndrome.